3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
15
Thoracic
4
Gastrointestinal
4
Plasma cell
3
Lymphoid
3
Head & Neck
3
Sarcoma
2
Other solid neoplasm
2
Genitourinary
2
Tumor-Agnostic
1
Other hematologic neoplasm
1
Gynecologic
1
CNS
1
Conditions
Motor Activity
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Head and Neck Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
Radiotherapy
215
Cyclophosphamide
210
Doxorubicin
207
Temozolomide
181
Ifosfamide
121
Filgrastim
111
Etoposide
101
Imatinib Mesylate
99
Vincristine
92
Gemcitabine
89
Bevacizumab
83
Irinotecan
79
Magnetic Resonance Spectroscopy
78
pembrolizumab
75
Radiation
66
Carboplatin
65
pazopanib
60
Methotrexate
60
Nivolumab
58
Cisplatin
58
fludarabine phosphate
56
Peripheral Blood Stem Cell Transplantation
56
Specimen Handling
53
Docetaxel
50
Busulfan
48
Trabectedin
47
Biopsy
47
Melphalan
46
Surgical Procedures, Operative
44
Paclitaxel
44
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Exercise Therapy
×
Sarcoma
×
Clear all
NCT04963517
2024-12-06
proGAIT
Universität Duisburg-Essen
Phase 2/3
Completed
11 enrolled
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled